Envestnet Asset Management Inc. Sells 21,520 Shares of Danaher Co. (NYSE:DHR)

Envestnet Asset Management Inc. decreased its position in shares of Danaher Co. (NYSE:DHR) by 1.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,105,659 shares of the conglomerate’s stock after selling 21,520 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.15% of Danaher worth $253,804,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the company. Gilbert & Cook Inc. boosted its holdings in Danaher by 2.5% in the fourth quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate’s stock valued at $401,000 after acquiring an additional 42 shares during the last quarter. Grimes & Company Inc. boosted its stake in shares of Danaher by 0.6% in the 4th quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate’s stock valued at $1,696,000 after purchasing an additional 43 shares during the last quarter. Dakota Community Bank & Trust NA grew its position in shares of Danaher by 16.4% during the 4th quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate’s stock worth $73,000 after buying an additional 45 shares during the period. Howard Capital Management Group LLC raised its stake in shares of Danaher by 4.1% during the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock worth $342,000 after buying an additional 48 shares during the last quarter. Finally, Spinnaker Trust lifted its holdings in Danaher by 1.2% in the fourth quarter. Spinnaker Trust now owns 4,304 shares of the conglomerate’s stock valued at $988,000 after buying an additional 50 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

DHR has been the subject of several recent research reports. Bank of America upgraded shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price for the company in a research report on Friday, December 13th. Guggenheim assumed coverage on Danaher in a research note on Thursday, December 19th. They issued a “buy” rating and a $275.00 target price on the stock. JPMorgan Chase & Co. decreased their target price on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Robert W. Baird cut their price target on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $277.00 target price (down previously from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Five equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $278.24.

Danaher Stock Down 8.3 %

Shares of DHR stock opened at $181.42 on Friday. The firm’s fifty day moving average price is $209.99 and its two-hundred day moving average price is $233.99. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. Danaher Co. has a 1 year low of $181.20 and a 1 year high of $281.70. The firm has a market capitalization of $129.66 billion, a P/E ratio of 34.36, a PEG ratio of 2.66 and a beta of 0.86.

Danaher (NYSE:DHR) last released its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the company earned $2.09 EPS. On average, equities analysts predict that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Friday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.71%. Danaher’s dividend payout ratio (DPR) is currently 24.24%.

Insider Buying and Selling

In other news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 11.10% of the stock is owned by corporate insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.